Characterization of inpatient care for patients admitted to a psychiatric hospital with a home opioid prescription
Introduction: Patients with mental illness are particularly at risk for OUD, and due to this higher risk, providers may be more inclined to withhold their home opioids when they are admitted to a psychiatric hospital. Patients whose home opioids are continued or withheld during admission may be trea...
Main Authors: | Kei Takamura, PharmD, BCPS, BCPP, Amy M. Hebbard, PharmD, BCPP, Sophie Robert, BPharm, PharmD, BCPP |
---|---|
Format: | Article |
Language: | English |
Published: |
American Association of Psychiatric Pharmacists
2023-03-01
|
Series: | Mental Health Clinician |
Subjects: | |
Online Access: | https://theijpt.org/doi/pdf/10.9740/mhc.2021.03.055 |
Similar Items
-
Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report
by: Menard Shannon PharmD, et al.
Published: (2021-11-01) -
Concurrent opioid and alcohol withdrawal management
by: Michelle Colvard, PharmD, BCPP
Published: (2023-12-01) -
Evaluation of drug-drug interactions in hospitalized patients on medications for OUD
by: Olivia Berger, PharmD, et al.
Published: (2021-07-01) -
Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone
by: Lindsay M. Mailloux, PharmD, et al.
Published: (2021-01-01) -
Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
by: Kim Ehrhard, PharmD, BCPP, et al.
Published: (2023-08-01)